ROYCE & ASSOCIATES LP - CUMBERLAND PHARMACEUTICALS I ownership

CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 22 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q3 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of CUMBERLAND PHARMACEUTICALS I
ValueSharesWeighting
Q3 2015$84,000
-19.2%
14,6000.0%0.00%
Q2 2015$104,000
+33.3%
14,600
+24.8%
0.00%
Q1 2015$78,00011,7000.00%
Other shareholders
CUMBERLAND PHARMACEUTICALS I shareholders Q3 2023
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 896,170$4,615,0003.22%
Ariel Investments 1,010,220$5,203,0000.06%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 183,000$942,0000.01%
Anfield Capital Management, LLC 4,530$23,0000.01%
Financial Gravity Asset Management, Inc. 2,000$10,0000.01%
Oakworth Capital, Inc. 3,052$16,0000.00%
BAILARD, INC. 11,816$61,0000.00%
DIMENSIONAL FUND ADVISORS LP 860,319$4,431,0000.00%
Renaissance Technologies 469,338$2,417,0000.00%
ACADIAN ASSET MANAGEMENT LLC 98,192$506,0000.00%
View complete list of CUMBERLAND PHARMACEUTICALS I shareholders